These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25301192)

  • 1. [Cellular immunotherapy as combination partners for the immune checkpoint blockade].
    Rössig C
    Oncol Res Treat; 2014; 37 Suppl 4():14-5. PubMed ID: 25301192
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoantigen heterogeneity: a key driver of immune response and sensitivity to immune checkpoint blockade?
    Furness AJ; Quezada SA; Peggs KS
    Immunotherapy; 2016 Jun; 8(7):763-6. PubMed ID: 27349975
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
    Jäger D; Jäger E; Bert F; Knuth A
    Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiation-enhanced immune response to cancer: workshop, Anaheim, CA, April 17, 2005.
    Sutherland RM
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):3-5. PubMed ID: 16377408
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer immunotherapy: a treatment for the masses.
    Blattman JN; Greenberg PD
    Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving receptor redirected adoptive cell therapy toward fine tuning of antitumor responses.
    Chicaybam L; Bonamino MH
    Int Rev Immunol; 2014 Oct; 33(5):402-16. PubMed ID: 24911925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer immunotherapy with MAGE antigens.
    Coulie PG
    Suppl Tumori; 2002; 1(4):S63-5. PubMed ID: 12415826
    [No Abstract]   [Full Text] [Related]  

  • 8. Chimeric T cells for adoptive immunotherapy of cancer: using what have we learned to plan for the future.
    Peinert S; Kershaw MH; Prince HM
    Immunotherapy; 2009 Nov; 1(6):905-12. PubMed ID: 20635906
    [No Abstract]   [Full Text] [Related]  

  • 9. Human cancer regression antigens.
    Kvistborg P; van Buuren MM; Schumacher TN
    Curr Opin Immunol; 2013 Apr; 25(2):284-90. PubMed ID: 23566921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer immunotherapy.
    Bender E
    Nature; 2017 Dec; 552(7685):S61. PubMed ID: 29293244
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined Immune Checkpoint Blockade.
    Drake CG
    Semin Oncol; 2015 Aug; 42(4):656-62. PubMed ID: 26320068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].
    Jäger E; Jäger D; Knuth A
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1011-6. PubMed ID: 11555776
    [No Abstract]   [Full Text] [Related]  

  • 13. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.
    Boon T; Coulie P; Marchand M; Weynants P; Wölfel T; Brichard V
    Important Adv Oncol; 1994; ():53-69. PubMed ID: 8206495
    [No Abstract]   [Full Text] [Related]  

  • 14. An introduction to tumour immunology.
    Keith J
    Mater Med Pol; 1984; 16(1):54-64. PubMed ID: 6394909
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigen choice in adoptive T-cell therapy of cancer.
    Offringa R
    Curr Opin Immunol; 2009 Apr; 21(2):190-9. PubMed ID: 19297140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cellular immunotherapy with genetically engineered T-cell therapy for malignancies].
    Fujiwara H
    Rinsho Ketsueki; 2011 May; 52(5):243-55. PubMed ID: 21646769
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional design of chimeric T-cell antigen receptors for adoptive immunotherapy of cancer: architecture and outcomes.
    Shirasu N; Kuroki M
    Anticancer Res; 2012 Jun; 32(6):2377-83. PubMed ID: 22641678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Suppression of tumor antigen-specific T cell immune responses by regulatory T cells].
    Shimazu Y; Nishikawa H
    Gan To Kagaku Ryoho; 2014 Sep; 41(9):1057-61. PubMed ID: 25248887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer immunotherapy.
    Falk RE
    Can Med Assoc J; 1979 Feb; 120(3):255, 258. PubMed ID: 311678
    [No Abstract]   [Full Text] [Related]  

  • 20. Links between genetics and immunology: mutations and antigens.
    Ayyoub M
    Bull Acad Natl Med; 2016 Jan; 200(1):67-79. PubMed ID: 29889414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.